Recent CMV Research

dc.contributor.author	Anamaris M. Colberg-Poley	en
dc.contributor.editor	M, Anamaris
dc.date.accessioned	2018-09-19T07:49:06Z
dc.date.accessioned	2023-07-20T09:12:11Z
dc.date.available	2018-09-19T07:49:06Z
dc.date.available	2023-07-20T09:12:11Z
dc.date.issued	2004
dc.identifier.isbn	978-3-906980-53-9
dc.identifier.uri	http://10.215.13.25/handle/123456789/2560
dc.description	In developed countries, human cytomegalovirus (CMV) is the major infectious cause of congenital birth defects including microcephaly, mental retardation, sensorineural hearing loss, and intrauterine growth restriction. Nonetheless, because of the potential for teratogenicity and toxic effects, no prenatal therapeutic treatment is currently approved by the Food and Drug Administration for congenital CMV infection. Therefore there is great interest in understanding CMV growth and blocking or altogether preventing CMV infection	en
dc.language.iso	en	en_US
dc.publisher	MDPI	en_US
dc.subject	CMV	en_US
dc.title	Recent CMV Research	en_US
dc.type	Book	en_US